Mineralys Therapeutics MLYS Earnings Call Transcripts

NASDAQ MLYS
$15.52 -0.29 (-1.83%)
At close: Nov 10, 2026 · 4:00 PM EST
3 earnings calls on file for Mineralys Therapeutics, from Q4 2025 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Mineralys Therapeutics Q2 2026 Earnings Call

Aug 11, 2026 6,636 words · 29 min read
  • Jon CongletonChief Executive Officer
  • Adam Scott LevyChief Financial Officer
  • Eric J. WarrenChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Mineralys Therapeutics Earnings Call Transcripts

Calls3
LatestAug 11, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 3 Mineralys Therapeutics transcripts Register to get access to Mineralys Therapeutics’s earnings call transcripts.